1-15 of 15
Daniela Voskova
Close
Sort by
Journal Articles

A phase 2 study of rituximab plus lenalidomide for mucosa-associated lymphoid tissue lymphoma

Clinical Trials & Observations
Barbara Kiesewetter, Ella Willenbacher, Wolfgang Willenbacher, Alexander Egle, Peter Neumeister, Daniela Voskova, Marius Erik Mayerhoefer, Ingrid Simonitsch-Klupp, Thomas Melchardt, Richard Greil, Markus Raderer
Journal: Blood
Blood (2017) 129 (3): 383–385.
https://doi.org/10.1182/blood-2016-06-720599
Published: 2017
Journal Articles

Azacitidine in Acute Myeloid Leukemia with >30% Bone Marrow Blasts and <15 G/L White Blood Cell Count: Results from the Austrian Azacitidine Registry of the AGMT Study Group Versus Randomized Controlled Phase III Clinical Trial Data

Lisa Pleyer, MD DI, Sonja Burgstaller, MD, Reinhard Stauder, MD MSc, Michael Girschikofsky, MD, Heinz Sill, MD, Konstantin Schlick, MD, Josef Thaler, MD, Britta Halter, MSc, Sigrid Machherndl-Spandl, MD, Armin Zebisch, MD, Angelika Pichler, MD, Michael Pfeilstöcker, MD, Eva-Maria Autzinger, MD, Alois Lang, MD, Klaus Geissler, MD, Daniela Voskova, MD, Dietmar Geissler, MD, Wolfgang R Sperr, MD, Sabine Hojas, MD, Inga Mandac Rogulj, MD, Johannes Andel, MD, Richard Greil, MD
Journal: Blood
Blood (2015) 126 (23): 2515.
https://doi.org/10.1182/blood.V126.23.2515.2515
Published: 2015
Journal Articles

Is It Time to Redefine Response in Elderly Patients with WHO-Acute Myeloid Leukemia (AML) Unfit for Intensive Chemotherapy?

Lisa Pleyer, MD DI, Sonja Burgstaller, MD, Reinhard Stauder, MD MSc, Michael Girschikofsky, MD, Heinz Sill, MD, Konstantin Schlick, MD, Josef Thaler, MD, Britta Halter, MSc, Sigrid Machherndl-Spandl, MD, Armin Zebisch, MD, Angelika Pichler, MD, Michael Pfeilstöcker, MD, Eva-Maria Autzinger, MD, Alois Lang, MD, Klaus Geissler, MD, Daniela Voskova, MD, Dietmar Geissler, MD, Wolfgang R Sperr, MD, Sabine Hojas, MD, Inga Mandac Rogulj, MD, Johannes Andel, MD, Richard Greil, MD
Journal: Blood
Blood (2015) 126 (23): 3742.
https://doi.org/10.1182/blood.V126.23.3742.3742
Published: 2015
Journal Articles

Azacitidine in Patients with Treatment-Related Acute Myeloid Leukemia: Retrospective Analysis of the Austrian Azacitidine Registry

Lisa Pleyer, MD DI, Sonja Burgstaller, MD, Reinhard Stauder, MD MSc, Michael Girschikofsky, MD, Werner Linkesch, Univ. Prof, MD, Michael Pfeilstöcker, MD, Eva Maria Autzinger, MD, Christoph Tinchon, MD, Thamer Sliwa, MD, Alois Lang, MD, Wolfgang R. Sperr, MD, Dietmar Geissler, Dr, Prof., Peter Krippl, MD, Daniela Voskova, Dr, MD, Dieter H. Rossmann, MD, Konstantin Schlick, Dr, Josef Thaler, MD, Britta Halter, MSc, Sigrid Machherndl-Spandl, MD, Georg Theiler, MD, Peter Valent, MD, Otto Eckmüllner, Dr, Richard Greil, MD
Journal: Blood
Blood (2014) 124 (21): 2284.
https://doi.org/10.1182/blood.V124.21.2284.2284
Published: 2014
Journal Articles

Azacitidine in Patients with Relapsed/Refractory Acute Myeloid Leukemia : Retrospective Analysis of the Austrian Azacitidine Registry

Lisa Pleyer, MD DI, Sonja Burgstaller, MD, Reinhard Stauder, MD MSc, Michael Girschikofsky, MD, Werner Linkesch, Univ. Prof, MD, Michael Pfeilstöcker, MD, Eva Maria Autzinger, MD, Christoph Tinchon, MD, Thamer Sliwa, MD, Alois Lang, MD, Wolfgang R. Sperr, MD, Dietmar Geissler, Dr, Prof., Peter Krippl, MD, Daniela Voskova, Dr, MD, Dieter H. Rossmann, MD, Konstantin Schlick, Dr, Josef Thaler, MD, Britta Halter, MSc, Sigrid Machherndl-Spandl, MD, Georg Theiler, MD, Peter Valent, MD, Otto Eckmüllner, Dr, Richard Greil, MD
Journal: Blood
Blood (2014) 124 (21): 943.
https://doi.org/10.1182/blood.V124.21.943.943
Published: 2014
Journal Articles

Azacitidine in Patients with Acute Myeloid Leukemia: Impact of Intermediate-Risk Vs High-Risk Cytogenetics on Patient Outcomes

Lisa Pleyer, MD DI, Sonja Burgstaller, MD, Reinhard Stauder, MD MSc, Michael Girschikofsky, MD, Werner Linkesch, Univ. Prof, MD, Michael Pfeilstöcker, MD, Eva Maria Autzinger, MD, Christoph Tinchon, MD, Thamer Sliwa, MD, Alois Lang, MD, Wolfgang R. Sperr, MD, Dietmar Geissler, Dr, Prof., Peter Krippl, MD, Daniela Voskova, Dr, MD, Dieter H. Rossmann, MD, Konstantin Schlick, Dr, Josef Thaler, MD, Britta Halter, MSc, Sigrid Machherndl-Spandl, MD, Georg Theiler, MD, Peter Valent, MD, Otto Eckmüllner, Dr, Richard Greil, MD
Journal: Blood
Blood (2014) 124 (21): 955.
https://doi.org/10.1182/blood.V124.21.955.955
Published: 2014
Journal Articles

Azacitidine in Patients with Acute Myeloid Leukemia: Assessing the Potential Negative Impact of Elevated Baseline White Blood Cell Count on Outcome

Lisa Pleyer, MD DI, Sonja Burgstaller, MD, Reinhard Stauder, MD MSc, Michael Girschikofsky, MD, Werner Linkesch, Univ. Prof, MD, Michael Pfeilstöcker, MD, Eva Maria Autzinger, MD, Christoph Tinchon, MD, Thamer Sliwa, MD, Alois Lang, MD, Wolfgang R. Sperr, MD, Dietmar Geissler, Dr, Prof., Peter Krippl, MD, Daniela Voskova, Dr, MD, Dieter H. Rossmann, MD, Konstantin Schlick, Dr, Josef Thaler, MD, Britta Halter, MSc, Sigrid Machherndl-Spandl, MD, Georg Theiler, MD, Peter Valent, MD, Otto Eckmüllner, Dr, Richard Greil, MD
Journal: Blood
Blood (2014) 124 (21): 3683.
https://doi.org/10.1182/blood.V124.21.3683.3683
Published: 2014
Journal Articles

Azacitidine in Acute Myeloid Leukemia: Comparison of Patients with AML-MRF Vs AML-NOS Enrolled in the Austrian Azacitidine Registry

Lisa Pleyer, MD DI, Sonja Burgstaller, MD, Reinhard Stauder, MD MSc, Michael Girschikofsky, MD, Werner Linkesch, Univ. Prof, MD, Michael Pfeilstöcker, MD, Eva Maria Autzinger, MD, Christoph Tinchon, MD, Thamer Sliwa, MD, Alois Lang, MD, Wolfgang R. Sperr, MD, Dietmar Geissler, Dr, Prof., Peter Krippl, MD, Daniela Voskova, Dr, MD, Dieter H. Rossmann, MD, Konstantin Schlick, Dr, Josef Thaler, MD, Britta Halter, MSc, Sigrid Machherndl-Spandl, MD, Georg Theiler, MD, Peter Valent, MD, Otto Eckmüllner, Dr, Richard Greil, MD
Journal: Blood
Blood (2014) 124 (21): 3681.
https://doi.org/10.1182/blood.V124.21.3681.3681
Published: 2014
Journal Articles

Multivariate Analysis of Prognostic Impact of Flow Cytometrically Determined Minimal Residual Disease in Patients with Acute Myeloid Leukemia.

Wolfgang Kern, MD, Daniela Voskova, MD, Claudia Schoch, MD, Susanne Schnittger, PhD, Torsten Haferlach, MD
Journal: Blood
Blood (2005) 106 (11): 2371.
https://doi.org/10.1182/blood.V106.11.2371.2371
Published: 2005
Journal Articles

Determination of Minimal Residual Disease in Patients with Acute Myeloid Leukemia by Multiparameter Flow Cytometry: Prognostic Impact at Different Checkpoints.

Wolfgang Kern, M.D., Daniela Voskova, M.D., Claudia Schoch, M.D., Wolfgang Hiddemann, M.D., Susanne Schnittger, Ph.D., Torsten Haferlach, M.D.
Journal: Blood
Blood (2004) 104 (11): 400.
https://doi.org/10.1182/blood.V104.11.400.400
Published: 2004
Journal Articles

Minimal Residual Disease in Patients with Acute Myeloid Leukemia Quantified by Multiparameter Flow Cytomety and Quantitative RT-PCR Is an Independent Prognostic Parameter.

Wolfgang Kern, M.D., Claudia Schoch, M.D., Torsten Haferlach, M.D., Daniela Voskova, M.D., Wolfgang Hiddemann, M.D., Susanne Schnittger, Ph.D.
Journal: Blood
Blood (2004) 104 (11): 319.
https://doi.org/10.1182/blood.V104.11.319.319
Published: 2004
Journal Articles

Flow Cytometric Characterization of Genetically Defined Subgroups of Chronic Lymphocytic Leukemia: Basis for the Comprehensive Definition of Prognostic Parameters.

Wolfgang Kern, M.D., Daniela Voskova, M.D., Claudia Schoch, M.D., Wolfgang Hiddemann, M.D., Susanne Schnittger, M.D., Torsten Haferlach, M.D.
Journal: Blood
Blood (2004) 104 (11): 4776.
https://doi.org/10.1182/blood.V104.11.4776.4776
Published: 2004
Journal Articles

Multiparameter Flow Cytometry Identifies Dysplasia in Granulocytic, Monocytic, and Erythrocytic Lineages and Blasts in Patients with Myelodysplastic Syndromes: Correlation with Cytomorphology and Cytogenetics.

Wolfgang Kern, M.D., Daniela Voskova, M.D., Claudia Schoch, M.D., Wolfgang Hiddemann, M.D., Susanne Schnittger, M.D., Torsten Haferlach, M.D.
Journal: Blood
Blood (2004) 104 (11): 2376.
https://doi.org/10.1182/blood.V104.11.2376.2376
Published: 2004
Journal Articles

Use of 5-Fold Staining for Multiparameter Flow Cytometry-Based Quantification of Minimal Residual Disease in Acute Myeloid Leukemia Results in Improved Sensitivity.

Wolfgang Kern, M.D., Daniela Voskova, M.D., Claudia Schoch, M.D., Wolfgang Hiddemann, M.D., Susanne Schnittger, Ph.D., Torsten Haferlach, M.D.
Journal: Blood
Blood (2004) 104 (11): 2025.
https://doi.org/10.1182/blood.V104.11.2025.2025
Published: 2004
Journal Articles

Determination of relapse risk based on assessment of minimal residual disease during complete remission by multiparameter flow cytometry in unselected patients with acute myeloid leukemia

Clinical Trials & Observations
Wolfgang Kern, Daniela Voskova, Claudia Schoch, Wolfgang Hiddemann, Susanne Schnittger, Torsten Haferlach
Journal: Blood
Blood (2004) 104 (10): 3078–3085.
https://doi.org/10.1182/blood-2004-03-1036
Published: 2004